The Construction and Validation of a New Ovarian Malignancy Probability Score (OMPS) for Prediction of Ovarian Malignancy

被引:0
作者
Arab, M. [1 ,2 ]
Yaseri, M. [3 ]
Farzaneh, M. [2 ]
Moridi, A. [2 ]
Tehranian, A. [4 ]
Sheibani, K. [2 ]
机构
[1] Shahid Beheshti Univ Med Sci, Canc Res Ctr, Tehran, Iran
[2] Shahid Beheshti Univ Med Sci, Imam Hossein Hosp, Tehran, Iran
[3] Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Tehran, Iran
[4] Univ Tehran Med Sci, Arash Hosp, Tehran, Iran
关键词
Logistic model; Ovarian mass; Ovarian cancer; Ultrasound; Risk of malignancy;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The best management for an ovarian mass is provided by appropriate prediction of malignancy. The aim of our study is to construct and validate a new Malignancy Probability Score based on four simple sonographic findings and age. Methods: In a cross sectional study; histopathological files of 3303 ovarian mass patients and tertiary hospitals, have reviewed within 6 years (2000-2006). Pathology, age, sonographic findings including solid area, ascetic, size and bilateralism were recorded. Logistic multivariate regression analysis SPSS18 has used to create malignancy probability scoring model. Our ovarian Malignancy Probability Score (OMPS) has constructed based on 80% of samples in a logistic regression model and has validated using the remainder of the cases. Results: Ovarian malignancy probability score (OMPS) has calculated as follow: age x 0.062 + Tumor size (cm) x 0.012+1.172(if the tumor is solid) + 1.289(if ascites is present) + 0.758(if the tumor is bilateral) Sensitivity of OMPS in prediction of malignancy with cutoff value of 3.65 score number was 77.9% and its specificity was 72.9% with Area under Curve (AUC) of 83% in ROC curve. Conclusion: OMPS is designed and tested in our research, to be proved as a simple and accurate clinical tool for ovarian malignancy prediction.
引用
收藏
页码:132 / 138
页数:7
相关论文
共 57 条
[1]  
Akbari M, 2008, IRAN CANC REPORT CAN
[2]   A new scoring system to differentiate benign from malignant adnexal masses [J].
Alcázar, JL ;
Mercé, LT ;
Laparte, C ;
Jurado, M ;
López-García, G .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2003, 188 (03) :685-692
[3]  
Alcazar JL, 2001, J ULTRAS MED, V20, P841
[4]  
*AM CANC SOC, 2007, CANC FACTS FIG
[5]  
Arab M, 2009, ASIAN PAC J CANCER P, V10, P1
[6]  
Australian institute of Health and welfare, 1998, AHW CAT
[7]  
BAADE P, 2000, CANC SURVIVAL QUEENS
[8]  
Balbi GC, 2001, EUR J GYNAECOL ONCOL, V22, P459
[9]  
Benign Reynolds K., 2004, OBSTET GENECOLOGY, P735
[10]  
Benjapibal Mongkol, 2003, J Med Assoc Thai, V86, P332